Please Wait

Applying Filters...

Terazol 7 3
EU WC
Table View

Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Terazol 7 3

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 2 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 10 FDA Orange Book, 1 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 7 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers, 12 Topical, 6 Emulsifying Agents, 6 Parenteral, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Surfactant & Foaming Agents, 2 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Nosch Labs Pvt	India	M/s Nosch Labs Pvt Ltd	WC-0027A4a	Terconazole Ph. Eur	2022-05-02	2025-07-25	Sy. No. 14, Gaddapotharam Village, IDA, Kazipally, Jinnaram Mandal, Sangareddy Dist.-502319, Telangana, India

Contact us
to update this info

Terazol 7 3

Terazol 7 3

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

2 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers

10 FDA Orange Book

1 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

1 Finar

4 Gangwal Chemicals

1 Nanjing Bold Chemical

7 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers

12 Topical

6 Emulsifying Agents

6 Parenteral

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Surfactant & Foaming Agents

2 Direct Compression

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Regulatory FDF Prices

MARKET PLACE

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM

2 Others

Filters

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons